Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
2000
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?
1999
Vulvovaginal candidosis
2007 Standout
Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis
1993
AIDS-Associated Cerebral Toxoplasmosis: An Update on Diagnosis and Treatment
1996
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS
1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance
1998
A randomized, double‐blind, placebo‐controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection
2001
Cancer to bone: a fatal attraction
2011 Standout
Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients
1997
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
2007
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Treatment of Fluconazole-Refractory Oropharyngeal Candidiasis with Itraconazole Oral Solution in HIV-Positive Patients
1999
Acute Respiratory Failure Associated with Cryptococcosis in Patients with AIDS: Analysis of Predictive Factors
1998
Recent Advances in the Management of Cryptococcal Meningitis in Patients with AIDS
1996
Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS Patients
1998
The metabolic syndrome
2010 Standout
A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40
2005
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
<![CDATA[<B>Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients</B>]]>
2001
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial
1996
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Iron status and the outcome of HIV infection: an overview
2001
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
The metabolic syndrome
2005 Standout
Cryptococcosis
2006
Participation in Cancer Clinical Trials
2004 Standout
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
1997 Standout
Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons
1999
Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency Virus
2002
Users' Guides to the Medical Literature
2000 Standout
Multimodal biomedical AI
2022 Standout
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000
2003
Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection
1998
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Malignant Gliomas in Adults
2008 Standout
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
2001 Standout
Meta-Analysis of Prophylactic Treatments Against Pneumocystis carinii Pneumonia and Toxoplasma Encephalitis in HIV-Infected Patients
1997
The Future of Antifungal Therapy
1996
Emerging Biological Principles of Metastasis
2017 Standout
Racial Differences in Factors that Influence the Willingness to Participate in Medical Research Studies
2002
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Biological properties of “naked” metal nanoparticles☆
2008
Once-Weekly Administration of Dapsone/Pyrimethamine vs. Aerosolized Pentamidine as Combined Prophylaxis for Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients
1995
Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection
1993
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
2001
The metabolic syndrome—a new worldwide definition
2005 Standout
Role of Azoles in Antifungal Therapy
1996
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Toxoplasma gondii: from animals to humans
2000 Standout
Reporting the study populations of clinical trials
2000
Recent Advances in Pulmonary Medicine
1993
Infection in Solid-Organ Transplant Recipients
2007 Standout
Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study
1999
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Adaptive designs in clinical trials: why use them, and how to run and report them
2018
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
FUNGAL INFECTIONS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
1997
Kaposi's Sarcoma
2000 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Randomized Study of Sulfamethoxazole-trimethoprim versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with AIDS
1995
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
1999
Anemia of Chronic Disease
2005 Standout
A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand
2002
Fluconazole
1995
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
2002
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Candida Infections: Outcome and Attributable ICU Costs in Critically Ill Patients
2000
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Prevention of Infection Due toPneumocystisspp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
2004
Heterogeneity of the Baseline Risk within Patient Populations of Clinical Trials: A Proposed Evaluation Algorithm
1998
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
A randomized trial of interferon-α2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma
1999
Infection Due to Fluconazole-Resistant Candida in Patients with AIDS: Prevalence and Microbiology
1997
Candida Infections: Outcome and Attributable ICU Costs in Critically Ill Patients
2000
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Invasive Candidiasis
2015 Standout
Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
2011
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans
1996
Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study
2005
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Mechanisms of Diabetic Complications
2013 Standout
Prevention of Infection Due toPneumocystis carinii
1998
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis
2019
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of Weili He being referenced
Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group.
1993
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
2010
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
1995
A Phase II Study of Recombinant Human Interferon-α2a and Zidovudine in Patients with AIDS-Related Kaposi's Sarcoma
1996
DIA’s Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for “Less Well-understood” Adaptive Designs
2016
Addressing Challenges and Opportunities of “Less Well-Understood” Adaptive Designs
2016
Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans
2004
A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency Syndrome
1992
Practical Considerations and Strategies for Executing Adaptive Clinical Trials
2012
Practical Considerations for Adaptive Trial Design and Implementation
2014
Alendronate with and without cholecalciferol for osteoporosis: results of a 15‐week randomized controlled trial
2006